Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2012

Open Access 01-12-2012 | Research article

Ultra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention

Authors: Darran Flynn, Damian Smith, Luke Quirke, Stephen Monks, Harry G Kennedy

Published in: BMC Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

The ultra high risk state for psychosis has not been studied in young offender populations. Prison populations have higher rates of psychiatric morbidity and substance use disorders. Due to the age profile of young offenders one would expect to find a high prevalence of individuals with pre-psychotic or ultra-high risk mental states for psychosis (UHR). Accordingly young offender institutions offer an opportunity for early interventions which could result in improved long term mental health, social and legal outcomes. In the course of establishing a mental health in-reach service into Ireland’s only young offender prison, we sought to estimate unmet mental health needs.

Methods

Every third new committal to a young offenders prison was interviewed using the Comprehensive Assessment of At-Risk Mental States (CAARMS) to identify the Ultra High Risk (UHR) state and a structured interview for assessing drug and alcohol misuse according to DSM-IV-TR criteria, the Developmental Understanding of Drug Misuse and Dependence - Short Form (DUNDRUM-S).

Results

Over a twelve month period 171 young male offenders aged 16 to 20 were assessed. Of these 39 (23%, 95% confidence interval 18% to 30%) met UHR criteria. UHR states peaked at 18 years, were associated with lower SOFAS scores for social and occupational function and were also associated with multiple substance misuse. The relationship with lower SOFAS scores persisted even when co-varying for multiple substance misuse.

Conclusions

Although psychotic symptoms are common in community samples of children and adolescents, the prevalence of the UHR state in young offenders was higher than reported for community samples. The association with impaired function also suggests that this may be part of a developing disorder. Much more attention should be paid to the relationship of UHR states to substance misuse and to the health needs of young offenders.
Appendix
Available only for authorised users
Literature
1.
Teplin LA, Abram KM, McClelland GM, Dulcan MK, Mericle AA: Psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry. 2002, 59: 1133-1143. 10.1001/archpsyc.59.12.1133.CrossRefPubMedPubMedCentral
2.
Fazel S, Doll H, Langstrom N: Mental disorders among adolescents in juvenile detention and correctional facilities: a systematic review and metaregression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry. 2008, 47: 1010-1019.PubMed
3.
Colins O, Vermeiren R, Vreugdenhil C, van den Brink W, Doreleijers T, Broekaert E: Psychiatric disorders in detained male adolescents: a systematic literature review. Can J Psychiatry. 2010, 55: 255-263.PubMed
4.
Lader D, Singleton N, Meltzer H: Psychiatric morbidity among young offenders in England and Wales. Int Rev Psychiatry. 2003, 15: 144-147. 10.1080/0954026021000046074.CrossRefPubMed
5.
The National Crime Council: Tackling The Underlying Causes of Crime: A Partnership Approach. 2002, The Stationary Office, Dublin
6.
Kutcher S, McDougall A: Problems with access to adolescent mental health care can lead to dealings with the criminal justice system. Paediatr Child Health. 2009, 14: 15-18.PubMedPubMedCentral
7.
Fazel S, Seewald K: Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry. 2012, 200: 364-373. 10.1192/bjp.bp.111.096370.CrossRefPubMed
8.
Linehan SA, Duffy DM, Wright B, Curtin K, Monks S, Kennedy HG: Psychiatric Morbidity in a Cross-Sectional Sample of Male Remanded Prisoners. Ir J Psych Med. 2005, 22: 128-132.CrossRef
9.
Duffy DM, Linehan SA, Kennedy HG: Psychiatric Morbidity in the Male Sentenced Irish Prisons Population. Ir J Psych Med. 2006, 23: 54-62.CrossRef
10.
Ginsberg Y, Lindefors N: Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. Br J Psychiatry. 2012, 200: 68-73. 10.1192/bjp.bp.111.092940.CrossRefPubMed
11.
Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, et al: The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res. 2005, 79: 85-93. 10.1016/j.schres.2005.05.024.CrossRefPubMed
12.
Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005, 62: 975-983. 10.1001/archpsyc.62.9.975.CrossRefPubMed
13.
Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al: Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl. 1998, 172: 14-20.PubMed
14.
Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al: Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res. 2008, 105: 10-17. 10.1016/j.schres.2008.07.012.CrossRefPubMed
15.
Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al: Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009, 35: 894-908. 10.1093/schbul/sbp027.CrossRefPubMedPubMedCentral
16.
Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, et al: Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry. 2009, 43: 818-829. 10.1080/00048670903107625.CrossRefPubMed
17.
Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al: Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry. 2004, 185: 291-297. 10.1192/bjp.185.4.291.CrossRefPubMed
18.
Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010, 67: 146-154. 10.1001/archgenpsychiatry.2009.192.CrossRefPubMed
19.
Yung AR, Nelson B: Young people at ultra high risk for psychosis: a research update. Early Interv Psychiatry. 2011, 5 (Suppl 1): 52-57.CrossRefPubMed
20.
Preti A, Cella M: Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res. 2010, 123: 30-36. 10.1016/j.schres.2010.07.026.CrossRefPubMed
21.
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al: Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005, 39: 964-971. 10.1080/j.1440-1614.2005.01714.x.CrossRefPubMed
22.
McGorry PD, Yung AR, Phillips LJ: The "close-in" or ultra-high risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull. 2003, 29 (4): 771-790. 10.1093/oxfordjournals.schbul.a007046.CrossRefPubMed
23.
Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al: Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003, 60: 21-32.CrossRefPubMed
24.
Hafner H, Riecher-Rossler A, Der An HW, Maurer K, Fatkenheuer B, Loffler W: Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med. 1993, 23: 925-940. 10.1017/S0033291700026398.CrossRefPubMed
25.
Jarrett M, Craig T, Parrott J, Forrester A, Winton-Brown T, Maguire H, et al: Identifying men at ultra high risk of psychosis in a prison population. Schizophr Res. 2012, 136: 1-6. 10.1016/j.schres.2012.01.025.CrossRefPubMed
26.
27.
28.
Goldman HH, Skodol AE, Lave TR: Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry. 1992, 149: 1148-1156.CrossRefPubMed
29.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Text Revision, 4
30.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). 2002, Biometrics Research, New York State Psychiatric Institute, New York
31.
Curtin K, Monks S, Wright B, Duffy DM, Linehan SA, Kennedy HG: Psychiatric Morbidity in 615 Male Sentenced and Remanded Committals to Irish Prisons. Ir J Psych Med. 2009, 26: 169-173.CrossRef
32.
Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al: Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008, 65: 28-37. 10.1001/archgenpsychiatry.2007.3.CrossRefPubMedPubMedCentral
33.
Ruhrmann S, Schultze-Lutter F, Klosterkotter J: Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry. 2003, 36 (Suppl 3): S162-S167.PubMed
34.
Bryant TN: Computer software for calculating confidence intervals. Statistics with confidence. Edited by: Altman DG, Machin D, Bryant T, Gardner MJ. 2000, BMJ Books, Bristol, 208-213. 2
35.
Duffy D, Linehan S, O'Neill H, Kennedy HG: Irish Travellers and forensic mental health. Irish Journal of Psychological Medicine. 2002, 19 (3): 76-79.CrossRef
36.
37.
Hambrecht M, Hafner H: Substance abuse and the onset of schizophrenia. Biological Psychiatry. 1996, 40: 1155-1163. 10.1016/S0006-3223(95)00609-5.CrossRefPubMed
38.
Lewis G, David A, Andreasson S, Allebeck P: Schizophrenia and city life. Lancet. 1992, 340: 137-140. 10.1016/0140-6736(92)93213-7.CrossRefPubMed
39.
Pedersen CB, Mortensen PB: Are the cause(s) responsible for urban-rural differences in schizophrenia risk rooted in families or in individuals?. Am J Epidemiol. 2006, 163: 971-978. 10.1093/aje/kwj169.CrossRefPubMed
40.
Wright B, Duffy DM, Curtin K, Linehan SA, Monks S, Kennedy HG: Psychiatric Morbidity among Women Prisoners newly Committed and amongst Remanded and Sentenced Women in the Irish Prison System. Ir J Psych Med. 2006, 23: 47-53.CrossRef
41.
Kelly BD: Structural violence and schizophrenia. Soc Sci Med. 2005, 61: 721-730. 10.1016/j.socscimed.2004.12.020.CrossRefPubMed
42.
Fazel S, Bains P, Doll H: Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006, 101: 181-191. 10.1111/j.1360-0443.2006.01316.x.CrossRefPubMed
43.
Casadio P, Fernandes C, Murray RM, Di FM: Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev. 2011, 35: 1779-1787. 10.1016/j.neubiorev.2011.04.007.CrossRefPubMed
44.
Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD: Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Aust N Z J Psychiatry. 2002, 36: 800-806. 10.1046/j.1440-1614.2002.01089.x.CrossRefPubMed
45.
Keshavan MS, Anderson S, Pettegrew JW: Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res. 1994, 28: 239-265. 10.1016/0022-3956(94)90009-4.CrossRefPubMed
46.
47.
Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N, et al: Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry. 2012, 201: 26-32. 10.1192/bjp.bp.111.101543.CrossRefPubMed
48.
Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al: Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr Bull. 2007, 33: 673-681. 10.1093/schbul/sbm015.CrossRefPubMedPubMedCentral
Metadata
Title
Ultra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention
Authors
Darran Flynn
Damian Smith
Luke Quirke
Stephen Monks
Harry G Kennedy
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2012
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-12-100

Other articles of this Issue 1/2012

BMC Psychiatry 1/2012 Go to the issue

Research article

French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms

Research article

Body dissatisfaction and body mass in girls and boys transitioning from early to mid-adolescence: additional role of self-esteem and eating habits

Study protocol

Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial

Research article

Impaired pitch identification as a potential marker for depression

Research article

Effectiveness of a self-help manual on the promotion of resilience in individuals with depression in Thailand: a randomised controlled trial

Study protocol

Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: design of a pragmatic randomised controlled trial